Mia's Feed
Medical News & Research

Identifying Gaps in Skin Cancer Care for Vulnerable Populations: Insights from Recent Research

Identifying Gaps in Skin Cancer Care for Vulnerable Populations: Insights from Recent Research

Share this article

Recent research reveals disparities in skin cancer diagnosis and treatment among older adults and rural residents, emphasizing the need for targeted strategies to improve early detection and care access for vulnerable populations.

2 min read

A comprehensive review conducted by Huntsman Cancer Institute at the University of Utah highlights significant disparities in skin cancer care, particularly affecting older adults, residents of rural areas, and individuals facing barriers to regular medical services. Published in the Surgical Clinics of North America, the study underscores that certain groups are at heightened risk of experiencing delays in diagnosis and suboptimal treatment outcomes for aggressive skin cancers such as melanoma, Merkel cell carcinoma (MCC), and advanced squamous and basal cell carcinomas.

The review emphasizes that early detection is crucial for effective treatment, yet not everyone benefits equally. Older adults, who account for the highest mortality rates associated with aggressive skin cancers, often encounter obstacles such as comorbidities, mobility issues, or lack of awareness, resulting in less frequent use of standard treatments. Similarly, rural populations face challenges like lengthy travel distances to specialized dermatologists and limited access to skin cancer education and preventive measures, leading to later-stage diagnoses.

The research also points out that some individuals are diagnosed only at advanced stages because they lack awareness of skin cancer signs, do not have regular healthcare providers, or the cancer develops in hard-to-see areas like the soles of the feet. As a result, these delays contribute to poorer outcomes among these at-risk groups.

To address these disparities, the review advocates for strategies such as expanding telehealth services, facilitating access to clinical trials, educating the public about skin cancer risks and early warning signs, and training healthcare providers to recognize skin cancer across all skin tones. Huntsman Cancer Institute is actively working to improve equity through outreach, education, and expanding access in rural and underserved communities, including establishing a new Comprehensive Cancer Center in Vineyard, Utah.

The findings reinforce that cancer care must be tailored to reach vulnerable populations effectively. As Dr. Elliot Asare, the review’s lead author, states, “Cancer care shouldn't be one-size-fits-all. We need to meet patients where they are and ensure everyone has the opportunity for early diagnosis and quality treatment.”

Source: https://medicalxpress.com/news/2025-07-gaps-skin-cancer-older-adults.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

U.S. Grants Final Approval to Novavax COVID-19 Vaccine Amid Delays and New Restrictions

The U.S. has officially approved Novavax's COVID-19 vaccine Nuvaxovid, with new restrictions limiting its use to certain high-risk groups, following a delayed approval process.

Innovative AI Model Enhances Mouse Brain Mapping for Neuroscience Discoveries

Researchers have developed an AI-powered mouse brain map with over 1,300 detailed regions, opening new horizons for neuroscience and disease research.

Innovative Compound CMX410 Offers New Hope Against Drug-Resistant Tuberculosis

A groundbreaking compound named CMX410 shows promise in targeting drug-resistant tuberculosis by irreversibly inhibiting a key bacterial enzyme, offering hope for more effective treatments.

Innovative Herpes Virus Engineering Enhances T Cell-Based Cancer Immunotherapy

A groundbreaking study from the University of Michigan explores how engineered herpes virus proteins can activate T cells, enhancing cancer immunotherapy and potentially improving outcomes for patients with tumors resistant to current treatments.